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Background
Control of HIV replication is determined by a complex
interaction of viral genetic, host genetic and immune fac-
tors, the understanding of which is crucial to developing
an effective vaccine. In some studies, HIV Gag immune
responses correlate with low viral loads and it is hypothe-
sised that some HLA alleles select for escape mutations in
conserved Gag epitopes, resulting in a fitness cost. We are
investigating the impact of HLA-driven variation in Gag
on fitness and disease progression in a population of 451
HIV-1 subtype C infected individuals.
Methods
Gag-Protease NL43 recombinant viruses were generated
by electroporation of a green fluorescent protein reporter
cell line with plasma-derived gag-protease PCR products
and pNL43Δgag-protease. The replication capacities of
recombinant viruses were determined by calculating the
slope of increase in percentage infected cells, as measured
by flow cytometry, from days 3–6 following infection.
Results
254 recombinant viruses have been generated and replica-
tion capacities determined for 115. Preliminary analysis
shows that overall there is no correlation between viral
load/CD4 count and fitness. However, the least fit viruses
(0.37–0.5, n = 14) were associated with lower viral loads
(Mann-Whitney, p = 0.009) but not significantly higher
CD4 counts when compared with those displaying high
fitness (0.75–0.94, n = 12). No statistically significant
associations were found between previously described
protective HLA types and fitness.
Conclusion
We have set up a system to measure the influence of sub-
type C Gag-Protease variability on fitness and generated a
means to further characterise functional consequences of
genetic variation. Preliminary results suggest that Gag-
Protease sequence variation can significantly impact on
viral fitness and that this may in turn have clinical signifi-
cance. More data may be required to test whether HLA
alleles influence Gag-Protease function at population-
wide level in HIV-1 subtype C infection.
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